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Abstract
An efficient, one-pot synthesis was developed for 3-aminoalkylated indoles by three-component coupling reaction
of aldehydes, N-methylanilines, and indoles using AgOTf as a catalyst. A series of twenty 3-aminoalkylated indoles
was evaluated for their antibacterial activities against both Gram negative and Gram positive bacteria. Compounds
4b and 4r showed good antibacterial activity against both Gram positive and Gram negative strains. However,
inversing the property of substituent (from 4r to 4q) resulted in the significant fall in the magnitude of
antibacterial activity against Escherichia coli.
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Introduction
Antimicrobial resistance continues to grow quickly
among key microbial pathogens and has become a
severe global problem in recent years. Bacterial resis-
tance to almost all available antibacterial agents has
been reported [1]. Because of this many infectious dis-
eases, such as HIV infection, staphylococcal infection,
tuberculosis, influenza, gonorrhea, candida infection,
and malaria, are becoming difficult to treat. Thus, along
with trying to control bacterial resistance there is an
urgent need for new potent classes of antibiotics with
novel modes of action.
The indole scaffold is a prominent and privileged
structural motif which is embodied in a myriad of nat-
ural products and molecules of pharmaceutical interest
in a variety of therapeutic areas [2,3]. They possess a
wide spectrum of biological activities such as antibacter-
ial [4], anticonvulsant, and antihypertensive activity. bis-
Indole-based compounds have been reported to have
broad-spectrum antibacterial activities against antibiotic-
resistant strains and are currently being pursued as topi-
cal agents (Figure 1) [5-7]. 1,2,3,4-Tetrahydropyrazino
[1,2] indoles [8] and triazino [[8],6-b] indoles [9] have
been reported to have antifungal properties. Hapalindole
A isolated from the blue green algae Hapalosiphon fonti-
nalis is a 3-substituted indole derivative. It exhibits
potent antibacterial and antimycotic activities [10]. The
antibacterial activity of 3-substituted indole derivatives
has not been much studied. Owing to interesting chemi-
cal and biological properties of indole molecules, devel-
opment of efficient methods that allow rapid access to
functionalized indoles with different substitution pat-
terns constitutes an emerging area in organic synthesis.
Multicomponent reactions have received a great atten-
tion of organic chemists as they can provide drug-like
molecules with several degrees of structural diversity in
a one-pot operation and offer significant advantages
over conventional linear-type syntheses such as high
atom economy and E-factors, low cost, reduction in
overall reaction time, and operational simplicity. There
are only a few methods available for the synthesis of 3-
aminoalkylated indoles which have been found in many
natural products. Recently, a one-pot multicomponent
method was developed for the synthesis of 3-aminoalky-
lated indoles by the reaction of aldehyde, amine, and
indole [11-14]. The reaction requires longer time, high
temperature, and is generally accompanied by formation
of bis-indolyl compound. Thus, there is still high need
for the development of an efficient and straightforward
method for the synthesis of 3-substituted indole
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provided the original work is properly cited.derivatives. In continuation to our interest in novel reac-
tion methodologies under environmentally friendly con-
ditions [15,16], we herein report an efficient silver
triflate catalyzed synthesis of 3-aminoalkylated indoles
and their antibacterial activities.
Experimental
General
Melting points were determined in open capillary tubes
on a MPA120-Automated Melting Point apparatus and
are uncorrected. The
1Ha n d
13C NMR spectra were
recorded on a Bruker Heaven 11400 (400 MHz) spectro-
meter using TMS as internal standard and the chemical
shifts are expressed in ppm. All the metal triflates, indole,
N-methylaniline, and aldehydes were purchased from
Sigma-Aldrich. The products were purified by column
chromatography using silica gel (60-120 mesh, S. D. Fine,
India). The bacterial cultures (Bacillus subtilis MTCC
121, Staphylococcus aureus MTCC 96 and Escherichia
coli MTCC 1652) were procured from Microbial Type
Culture Collection, Institute of Microbial Technology,
Chandigarh, India. Dimethyl sulfoxide (DMSO) and
chloramphenicol (standard broad spectrum antibiotic)
were used as negative and positive controls, respectively.
The experiments were carried out in triplicates.
General procedure for preparation of 3-aminoalkylated
indoles (4)
To a solution of N-methylaniline (114 mg, 1.2 mmol)
and a benzaldehyde (1.0 mmol) in acetonitrile (10 mL),
AgOTf (30 mg) was added. The reaction mixture was
stirred at room temperature. After 30 min, indole or N-
methylindole (0.71 mmol) was added to the reaction
and the mixture was allowed it to stir for an additional
90 min. The progress of reaction was monitored by
TLC. After completion of the reaction, solvent was
removed under reduced pressure. To the residue, diethyl
ether was added and filtered. The filtrate was dried over
anhydrous sodium sulfate and concentrated to obtain
the crude product, which was purified by column
chromatography on silica gel (100-200 mesh) using ethyl
acetate/hexane as eluents to yield a pure product (4a-
4r). All the compounds were characterized by ESI-
MS,
1H NMR, and
13C NMR spectroscopic data.
N-((4-Chlorophenyl)(1H-indol-3-yl)methyl)-N-
methylbenzenamine (4a)
Brown solid, m.p. 183-185°C;
1H NMR (400 MHz,
CDCl3): δ 7.98 (s, 1H), 7.37 (d, J = 4.0 Hz, 2H), 7.27-
7.16 (m 5H), 7.03 (d, J = 8.0 Hz, 3H), 6.57 (d, J =8 . 0
Hz, 3H), 5.55 (s, 1H), 2.83 (s, 3H);
13C NMR (100 MHz,
DMSO-d6): δ 147.5, 141.6, 137.0, 135.5, 132.9, 129.8,
129.1, 129.0, 127.3, 124.2, 121.9, 120.8, 120.2, 119.3,
113.1, 111.2, 47.6, 31.0, 21.1; ESI-MS (m/z): 346.9975
[M + H]
+.
N-((1H-Indol-3-yl)(p-tolyl)methyl)-N-methylbenzenamine
(4b)
Brown solid, m.p. 136-138°C;
1H NMR (400 MHz,
DMSO-d6): δ 10.62 (s, 1H), 7.31 (d, J =8 . 0H z1 H ) ,
7.07-6.98 (m, 7H), 6.92-6.90 (m, 1H), 6.62-6.61 (m,
1H), 6.43 (d, J = 8.4 Hz, 2H), 5.46 (s, 1H), 5.40 (s, 1H),
2.49-2.48 (m, 3H), 2.24 (s, 1H);
13C NMR (100 MHz,
DMSO-d6): δ 147.6, 141.7, 136.7, 135.4, 133.2, 129.7,
128.9, 128.8, 127.2, 123.9, 121.9, 120.9, 120.1, 119.3,
112.4, 111.0, 47.6, 31.0, 21.1; ESI-MS (m/z): 327.0665
[M + H]
+.
N-((1H-Indol-3-yl)(4-methoxyphenyl)methyl)-N-
methylbenzenamine (4c)
Brown solid, m.p. 177-179°C;
1H NMR (400 MHz,
CDCl3): δ 7.93 (s, 1H), 7.42-7. 26 (m, 3H), 7.16 (d, J =
7.6 Hz, 3H), 7.06-6.98 (m, 3H), 6.83 (d, J =7 . 6 ,2 H ) ,
6.56 (d, J = 8.0 Hz, 3H), 5.54 (s, 1H), 3.80 (s, 3H), 2.83
(s, 3H);
13C NMR (100 MHz, CDCl3): δ 168.98, 157.90,
147.56, 136.99, 133.29, 129.85, 129.65, 127.13, 123.90,
121.97, 120.16, 119.27, 113.56, 112.40, 110.97, 55.21,
47.13, 30.95; ESI-MS (m/z): 343.0446 [M + H]
+.
N-((1H-Indol-3-yl)(phenyl)methyl)-N-methylbenzenamine
(4d)
Brown solid, mp 189-191°C;
1H NMR (400 MHz,
DMSO-d6): δ 10.01 (s, 1H), 7.57 (s, 1H), 7.35 (d, J =8 . 0
Hz, 1H), 7.26-7.20 (m, 4H), 7.17-7.14 (m, 2H), 7.09-6.86
(m, 3H), 6.60 (d, J = 2.0 Hz, 3H), 5.53 (s, 1H), 2.79 (s,
3H);
13C NMR (100 MHz, CDCl3): δ 147.7, 144.9, 133.0,
130.1, 129.8, 129.0, 128.2, 127.2, 124.0, 122.0, 120.7,
120.1, 119.3, 112.4, 111.0, 48.0, 31.0; ESI-MS (m/z):
313.0450 [M + H]
+.
N-((1H-Indol-3-yl)(4-hydroxy phenyl)methyl)-N-
methylbenzenamine (4e)
Brown solid, m.p. 139-140°C;
1H NMR (400 MHz,
CDCl3): δ 7.929 (s, 3H), 7.41-7.01 (m, 7H), 6.75-6.57 (m,
N
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Figure 1 Chemical structure of bis-indole derivatives used as
antibacterial agents.
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Page 2 of 74H), 5.84 (s, 1H), 5.31 (s, 1H), 2.83 (s, 3H);
13CN M R
(100 MHz, CDCl3): δ 153.8, 136.8, 133.5, 130.5, 130.1,
129.9, 127.1, 123.9, 123.6, 122.0, 120.0, 119.3, 115.1,
112.3, 111.1, 47.1, 39.5, 31.0; ESI-MS (m/z): 329.0347
[M + H]
+.
N-((4-Hydroxy-3-bromophenyl)(1H-indol-3-yl)methyl)-N-
methylbenzenamine (4f)
Brown solid, m.p. 187-189°C;
1H NMR (400 MHz,
CDCl3): δ 7.97 (s, 1H), 7.38-7.19 (m, 4H), 7.08-6.93 (m,
5H), 6.59 (s, 3H), 5.50 (s, 1H), 2.84 (s, 3H);
13CN M R
(100 MHz, CDCl3): δ 150.3, 147.6, 138.5, 136.9, 132.0,
129.7, 129.6, 127.0, 123.9, 123.6, 122.6, 122.1, 119.9,
119.4, 115.7, 112.6, 111.1, 110.1, 46.9, 31.0; ESI-MS (m/
z): 406.9101 [M + H]
+.
N-((1H-Indol-3-yl)(3-methoxyphenyl)methyl)-N-
methylbenzenamine (4g)
Brown solid, m.p. 136-139°C;
1H NMR (400 MHz,
CDCl3): δ 7.939 (s, 2H), 7.43-7.22 (m, 3H), 7.20-7.17 (m,
3H), 7.08-6.86 (m, 2H), 6.84-6.81 (m, 2H), 6.57 (d, J =
7.6 Hz, 2H), 5.56 (s, 1H), 3.75 (s, 3H), 2.83 (s, 3H);
13C
NMR (100 MHz, CDCl3): δ 159.5, 148.5, 147.6, 146.5,
145.8, 136.7, 132.9, 129.7, 127.1, 123.9, 123.6, 122.0,
121.6, 120.1, 120.0, 115.0, 112.5, 111.2, 110.1, 55.5, 48.0,
31.0; ESI-MS (m/z): 343.0968 [M + H]
+.
N-((1H-Indol-3-yl)(2,4-dimethoxyphenyl)methyl)-N-
methylbenzenaminen (4h)
Brown solid, m.p. 123-126°C;
1H NMR (400 MHz,
CDCl3): δ 7.91 (s, 1H), 7.34-7.27 (m, 2H), 7.16-6.92 (m,
4H), 6.57-6.37 (m, 4H), 5.59 (s, 1H), 3.79 (s, 6H), 2.83
(s, 3H);
13C NMR (100 MHz, CDCl3): δ 159.9, 157.9,
147.3, 136.8, 130.2, 130.0, 129.7, 125.7, 125.0, 123.9,
121.8, 120.2, 119.1, 112.4, 112.3, 110.9, 103.8, 95.6, 55.7,
55.3, 39.1, 31.1; ESI-MS (m/z): 373.0427 [M + H]
+.
N-Methyl-N-((1-methyl-1H-indol-3-yl)(phenyl)methyl)
benzenamine (4i)
Brown solid, mp 189-191°C;
1H NMR (400 MHz, CDCl3):
δ 7.28-7.22 (m, 8H), 7.04 (d, J = 8.0 Hz, 4H), 6.58-6.45
(m, 3H), 5.59 (s, 1H), 3.71 (s, 3H), 2.84 (s,3H);
13CN M R
(100 MHz, CDCl3): δ 129.73, 128.97, 128.71, 128.35,
128.18, 125.94, 124.55, 122.32, 121.67, 121.52, 121.52,
120.18, 119.04, 118.72, 112.37, 109.06, 94.27, 47.90,
32.68, 30.93. ESI-MS (m/z): 327.055 [M + H]
+.
N-((4-Chlorophenyl)(1-methyl-1H-indol-3-yl)methyl)-N-
methylbenzenamine (4j)
Brown solid, m.p. 208-210°C;
1H NMR (400 MHz,
CDCl3): δ 7.29-7.18 (m, 7H), 7.03 (d, J =8 . 0H z ,3 H ) ,
6.57 (d, J = 4.0 Hz, 4H), 6.42 (s, 1H), 5.54 (s, 1H), 3.71
(s, 3H), 2.84 (s, 3H);
13C NMR (100 MHz, CDCl3): δ
147.8, 143.5, 137.5, 132.5, 131.6, 130.9, 130.3, 130.2,
129.7, 129. 6, 128.7, 128.5, 128.3, 121.7, 120.5, 118.9,
118.6, 112.6, 112.4, 109.2, 47.3, 32.7, 30.9. ESI-MS (m/z):
361.002 [M + H]
+.
N-Methyl-N-((1-methyl-1H-indol-3-yl)(p-tolyl)methyl)
benzenamine (4k)
Brown solid, m.p. 202-204°C;
1H NMR (400 MHz,
CDCl3): δ 7.31-7.26 (m, 3H), 7.19-7.01 (m, 8H), 6.57 (d,
J =8 . 0H z ,2 H ) ,6 . 4 6( s ,1 H ) ,5 . 5 6( s ,1 H ) ,3 . 7 1( s ,3 H ) ,
2.84 (s, 3H), 2.35 (s, 3H);
13C NMR (100 MHz, CDCl3): δ
147.6, 142.0, 137.5, 135.3, 133.9, 129.7, 128.9, 128.8,
128.7, 127.5, 121.5, 120.2,119.2, 118.7, 112.4, 109.0, 47.5,
32.7, 31.0, 21.1; ESI-MS (m/z): 341.066 [M + H]
+.
N-((1H-indol-3-yl)(3-nitrophenyl)methyl)-N-
methylbenzenamine (4l)
Brown solid, m.p. 193-194°C;
1H NMR (400 MHz,
CDCl3): δ 8.13-8.07 (m, 3H), 7.59 (d, J =8 . 0H z ,1 H ) ,
7.46-7.38 (m, 2H), 7.21 (d, J = 8.0 Hz, 2H), 7.06-7.02
(m, 3H), 6.66-6.57 (m, 3H), 5.68 (s, 1H), 2.84 (s, 3H);
13C
(100 MHz, CDCl3): δ 148.1, 147.8, 146.8, 136.5, 134.9,
130.9, 129.4, 128.8, 126.4, 123.8, 123.5, 122.1, 121.1,
119.4, 119.4, 119.1, 112.3, 112.2, 111.0, 47.5, 30.6; ESI-
MS (m/z): 358.007 [M + H]
+.
N-((5-Bromo-1H-indol-3-yl)(phenyl)methyl)-N-
methylbenzenamine (4m)
Brown solid, m.p. 207-209°C;
1H NMR (400 MHz,
CDCl3): δ 8.07 (s, 1H), 7.39 (s, 1H), 7.27-7.23 (m, 7H),
7.02 (d, J = 8.0 Hz, 2H), 6.58 (d, J = 8.0 Hz, 3H), 5.52 (s,
1H), 2.83 (s, 3H);
13C NMR (100 MHz, CDCl3): δ 147.5,
144.3, 135.4, 132.7, 129.7, 128.9, 128.3, 126.2, 125.2,
125.0, 122.5, 120.4, 112.7, 112.5, 47.7, 31.1; ESI-MS (m/
z): 390.9823 [M + H]
+ and 392.9105 [M + 2 + H]
+.
N-((5-Methoxy-1H-indol-3-yl)(4-methoxyphenyl)methyl)-N-
methylbenzenamine (4n)
Brown solid, m.p. 203-205°C;
1H NMR (400 MHz,
DMSO-d6): δ 10.62 (s, 1H), 7.24-7.20 (m, 3H), 7.09 (d, J
= 4.0 Hz, 1H), 6.91 (d, J =8 . 0H z ,1 H ) ,6 . 8 1( d ,J =8 . 0
Hz, 2H), 6.77 (s, 1H), 6.70-6.66 (m, 3H), 6.60-6.53 (m,
1H), 6.43 (d, J = 8.0 Hz, 1H), 5.66 (s, 1H), 3.68 (s, 3H),
3.44 (s, 3H), 2.48 (s, 3H);
13C NMR (100 MHz, DMSO-
d6): δ 157.8, 153.1, 137.7, 132.3, 129.9, 129.7, 129.4,
127.4, 124.7, 118.5, 113.8, 112.5, 111.9, 111.0, 102.0,
55.7, 55.4, 47.0, 30.4; ESI-MS (m/z): 373.1681 [M + H]
+.
N-((5-Methoxy-1H-indol-3-yl)(p-tolyl)methyl)-N-
methylbenzenamine (4o)
Brown solid m.p. 197-199°C;
1H NMR (400 MHz,
DMSO-d6): δ 10.60 (s, 1H), 7.21 (d, J = 4.0 Hz, 3H),
7.06 (d, J = 8.0 Hz, 3H), 6.91 (d, J = 4.0 Hz, 1H), 6.77 (s,
1H), 6.69-6.66 (m, 3H), 6.59-6.52 (m, 1H), 6.42 (d, J =
8.0 Hz, 1H), 5.66 (s, 1H), 3.57 (s, 3H), 2.48 (s, 3H), 2.23
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13C NMR (100 MHz, DMSO-d6): δ 153.1, 148.9,
142.5, 135.0, 132.3, 129.5, 129.1, 128.9, 128.7, 127.5,
124.7, 118.3, 112.4, 111.9, 110.9, 102.0, 55.7, 47.4, 30.4,
21.1; ESI-MS (m/z): 357.1747 [M + H]
+.
N-((5-Bromo-1H-indol-3-yl)(p-tolyl)methyl)-N-
methylbenzenamine (4p)
Brown solid, m.p. 195-197°C;
1H NMR (400 MHz,
DMSO-d6): δ 11.02 (s, 1H), 7.29 (d, J = 8.0 Hz, 1H),
7.19 (d, J =4 . 0H z ,1 H ) ,7 . 1 1( d ,J =4 . 0H z ,1 H ) ,7 . 0 8 -
7.00 (m, 4H), 6.89 (d, J = 4.0 Hz, 2H), 6.75 (d, J =8 . 0
Hz, 1H), 6.68 (d, J =4 . 0H z ,1 H ) ,6 . 4 2( d ,J =8 . 0H z ,
2H), 5.39 (s, 1H), 2.48 (s, 3H), 2.22 (s, 3H);
13CN M R
(100 MHz, DMSO-d6): δ 148.7, 142.4, 135.7, 135.3,
131.7, 129.4, 129.2, 128.7, 126.0, 123.9, 121.7, 119.4,
114.0, 112.0, 111.3, 47.0, 30.4, 21.1; ESI-MS (m/z):
405.0683 [M + H]
+ and 407.072 [M + 2 + H]
+.
4-Chloro-N-((4-chlorophenyl)(5-methoxy-1H-indol-3-yl)
methyl)benzenamine (4q)
Brown solid, m.p. 190-191°C;
1H NMR (400 MHz,
DMSO-d6): δ 11.02 (s,1H), 7.29 (d, J = 4.0 Hz, 1H), 7.19
(s, 1H), 7.11 (d, J = 4.0 Hz, 1H), 7.07 (d, J =4 . 0H z ,
2H), 6.89 (d, J = 4.0 Hz, 2H), 6.83 (d, J = 8.0 Hz, 3H),
6.67 (s, 1H), 6.43 (d, J = 4.0 Hz, 2H), 5.39 (s, 1H), 3.69
(s, 3H), 2.47(s, 3H);
13C NMR (100 MHz, DMSO-d6): δ
157.8, 148.6, 137.4, 135.8, 131.7, 129.8, 129.4, 128.9,
126.0, 123.9, 121.8, 119.3, 114.0, 112.0, 111.1, 55.4, 46.6,
30.4; ESI-MS (m/z): 421.0695 [M + H]
+.
N-((4-Chlorophenyl)(5-methoxy-1H-indol-3-yl)methyl)-N-
methylbenzenamine (4r)
Brown solid, m.p. 201-203°C;
1H NMR (400 MHz,
DMSO-d6): δ 10.60 (s, 1H), 7.31-7.28 (m, 5H), 7.22-7.17
(m, 2H), 6.91 (s, 1H), 6.79 (s, 1H), 6.69 (s, 2H), 6.52 (s,
1H), 6.43 (d, J = 4.0 Hz, 2H), 5.73 (s, 1H), 3.30 (s, 3H),
2.47(s, 3H);
13C NMR (100 MHz, DMSO-d6): δ 153.2,
148.9, 144.6, 132.3, 131.2, 130.8, 130.6, 129.5, 128.4,
127.3, 125.3, 125.2, 124.8, 117.7, 112.6, 112.0, 111.1,
55.7, 47.3, 30.3; ESI-MS (m/z): 377.1223 [M + H]
+.
N-((4-chlorophenyl)(5-methoxy-1H-indol-3-yl)methyl)
benzenamine (4s)
Brown solid, m.p. 198-201°C;
1H NMR (400 MHz,
MeOH) δ 7.258-7.164 (m, 6H), 6.95 (d, J = 8.0 Hz, 2H),
6.73-6.55 (m, 3H), 6.53 (d, J = 10.0 Hz, 2H), 5.47 (s, 1H),
3.61 (s, 3H);
13C NMR (100 MHz, DMSO-d6): δ 154.7,
148.3, 141.3, 132.3, 130.9, 129.3, 128.9, 128.7, 128.2,
123.4, 117.5, 112.5, 112.3, 112.1, 110.7, 109.5, 55.3; ESI-
MS (m/z): 363.21 [M + H]
+, 365.20 [M + H +2]
+.
Anti-bacterial assay
Zone of inhibition assay was performed at 128 μgm L
-1
concentration for all the compounds (4a-s) using disk
diffusion method [17]. For this purpose, Mueller-Hilton
(HiMedia, India) agar medium was prepared and steri-
lized by autoclaving at 121°C at 15 psi for 15 min. The
medium was poured into sterile Petri dishes under asep-
tic conditions using laminar air flow chamber. After the
solidification of medium, the suspension of the test
organism (10
6 cfu mL
-1) was swabbed onto the indivi-
dual media plates using a sterile glass spreader. A sterile
disk (9-mm diameter) impregnated with compound was
placed over media surface and the plates were incubated
at 37°C for 18-24 h under dark conditions. The determi-
nation as to whether the organism is susceptible, inter-
mediate, or resistant was made by measuring the size of
zone of inhibition in comparison with standard
antibiotic.
MIC assay was performed to determine the lowest
concentration of compound necessary to inhibit a test
organism. MIC values were evaluated for all the com-
pounds (4a-t) using broth microdilution method as per
the standard guidelines [18]. Assay was carried out for
the compounds at 0.5, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0, 64.0,
128.0 μgm L
-1 concentrations. A set of tubes contain-
ing Muller Hilton broth medium with different con-
centrations of compounds were prepared. The tubes
were inoculated with bacterial cultures (10
6 cfu mL
-1)
and incubated on a rotary shaker (180 rpm) at 37°C
for 18-24 h under dark conditions. MIC values were
defined as lowest concentration of compound that pre-
vented the visible growth of bacteria after the incuba-
tion period. All the experiments were performed in
three replicates.
Results and discussion
Chemistry
Initially, we investigated reaction of indole benzalde-
hyde, and N-methylaniline to give 4a in acetonitrile
using different Lewis acid catalysts (Table 1). Among
different catalysts studied AgOTf gave highest yield of
4a (Table 1, entry 2). Among other catalysts, Ce(OTf)3,
Yb(OTf)3 and pTSA gave good yield of 4a (Table 1,
entries 7, 10, and 12). Formation of bis(indolyl)methane
(5-32%) as side product was observed with most of the
catalyst studied except with AgOTf, Ce(OTf)3,a n dY b
(OTf)3.
Subsequently, we investigated different solvents such
as DCM, DMSO, DMF, THF, acetonitrile, and ionic
liquid [bmim][BF4] for the model reaction. Acetonitrile
was found to give highest yield of 4a among all the
screened solvent. In case of ionic liquid [bmim][BF4]
imine was major product. In other solvents substrate
did not consume completely and there was mixture of
starting material, imine, and 4a. For further studies we
selected AgOTf (10 mol%) as catalyst and acetonitrile as
reaction medium of choice.
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we next studied the substrate scope by taking indoles,
aldehydes, and N-methyl anilines bearing different sub-
stituent for the synthesis of 3-aminoalkylated indoles
(4). The results are summarized in Table 2. The struc-
ture of the synthesized compounds was confirmed by
1H
NMR,
13C NMR, and mass spectroscopic data. A wide
range of structurally diverse aldehydes gave the corre-
sponding product 4 in good to excellent yields. Aro-
matic aldehyde having an electron-donating group gave
higher yield as compared to aromatic aldehydes with
electron withdrawing group (entry 12, Table 2). The
reaction was equally effective for N-methylindole and 5-
unsubstituted indoles affording the desired 3-aminoalky-
lated indoles in almost equally high yields (entries 13-
18, Table 2). However, poor yield of corresponding 3-
substituted indole was obtain e df r o ma n i l i n e( e n t r y1 9 ,
Table 1). When aliphatic amines were used it did not
result in 3-substituted indole under these conditions.
Then, we investigated the possibility of recycling of
the catalyst. After the first cycle for model reaction, the
solvent was concentrated under vacuum. Diethyl ether
was added to the residue obtained and filtered leaving
behind AgOTf. The recovered AgOTf was again taken
in a round bottom flask and charged with 4-chloroben-
zaldehyde (1a), N-methylaniline (3), and acetonitrile and
allowed to react for 30 min followed by the addition of
indole and reaction was allowed to continue for addi-
t i o n a l9 0m i n .T h ea b o v es e q u e n c ew a sr e p e a t e df o u r
times to give 4a in good yields (88, 85, 83, and 80%)
without much loss in catalytic activity of catalyst.
The reaction is assumed to proceed through two-step
domino sequence. The first step is believed to be forma-
tion of iminium ion after reaction of the benzaldehyde
and N-methylaniline. The next step is nucleophilic
attack of indole on iminium ion followed by proton loss
to give a 3-substituted indole. The structure of product
is consistent with the synthesis of 3-aminoalkylated
indoles via multicomponent condensation reaction of
indoles, aldehyde, and amines [11-14].
Anti-bacterial activity
An array of 20 diversely substituted indoles was evalu-
ated for in vitro antibacterial activity against both Gram
positive and Gram negative bacteria. The results of anti-
bacterial activity of compounds (4a-r)a r es h o w ni n
Table 2. The compounds indicating notable antibacterial
activity are indicated in bold (Table 2). Compounds 4q,
4r, 4i,a n d4b showed significant antibacterial activity
against Gram positive bacteria and 4r, 4b, 4o,a n d4l
Table 1 Optimization of reaction condition for model
reaction generating 4a
Number Catalyst (Catalyst mol
%)
Solvent Time
(h)
Yield (%)
a
1 AgOTf 1 CH3CN 4 58
2 AgOTf 5 CH3CN 4 78
3 AgOTf 10 CH3CN 4 86
4 Sc(OTf)3 10 CH3CN 4 43
5 Ga(OTf)3 10 CH3CN 4 45
6 Zn(OTf)2 5C H 3CN 4 52
7 Ce(OTf)3 5C H 3CN 4 71
8 Cu(OTf)2 5C H 3CN 4 68
9 Ba(OTf)2 5C H 3CN 4 50
10 Yb(OTf)3 5C H 3CN 4 72
11 FeCl3 5C H 3CN 2 59
12 pTSA 5 CH3CN 3 71
13 BF3.OEt2 5C H 3CN 5 34
14 Mont. K-
10
-
b CH3CN 6 15
15 SiO2 -
b CH3CN 6 30
16 AgOTf 10 DCM 10 67
17 AgOTf 10 DMSO 10 72
18 AgOTf 10 DMF 10 62
19 AgOTf 10 THF 10 58
20 AgOTf 10 [bmim]
[BF4]
12 31
c
21 AgOTf 10 H2O1 2 -
d
aIsolated yield
b100 mg mole of benzaldehyde
cImine was formed as major product
dNo product formation was observed.
Table 2 Synthesis of 3-aminoalkylated indoles (4a-t)
catalyzed by AgOTf
Number R R’ R’’ R’’’ Product Yield (%)
a
1 H H 4-Cl CH3 4a 86
b
2 H H 4-CH3 CH3 4b 85
3 H H 4-CH3OC H 3 4c 84
4H H H C H 3 4d 76
5 H H 4-OH CH3 4e 77
6 H H 3-Br, 4-OH CH3 4f 85
7 H H 3-CH3OC H 3 4g 83
8 H H 2,4-CH3OC H 3 4h 80
9H C H 3 HC H 3 4i 77
10 H CH3 4-Cl CH3 4j 76
11 H CH3 4-CH3 CH3 4k 77
12 H H 3-NO2 CH3 4l 48
13 5-Br H H CH3 4m 75
14 5-OCH3 H 4-OCH3 CH3 4n 85
15 5-OCH3 H 4-CH3 CH3 4o 82
16 5-Br H 4-CH3 CH3 4p 80
17 5-Br H 4-OCH3 CH3 4q 79
18 5-OCH3 H 4-Cl CH3 4r 81
19 5-OCH3 H 4-Cl H 4s 45
aIsolated yield.
bYield for four consecutive cycles for recycled AgOTf were 86, 84, 80 and 78,
respectively.
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that analog 4b and 4r can be used as potential broad
spectrum antibacterial agents as they are potent against
both Gram positive and Gram negative bacteria.
Compound 4d (without functional groups) was not
showing any antibacterial activity, however, substitution
of electron withdrawing groups at phenyl ring (4l, 4f)
exhibited increase in antibacterial activity against Gram
negative organisms. Interestingly, introduction of elec-
tron-releasing group at phenyl ring (4b)s h o w e dg o o d
activity against both the Gram positive and Gram nega-
tive bacterial strains.
Among the compounds 4i-k,t h ec o m p o u n d4i
showed antibacterial activity against only B. subtilis but
substituting the R’’ position with an electron withdraw-
ing group (4j, chloro) results in relatively less activity. In
contrast, introducing an electron-releasing group at R’’
position (4k, methoxy) made it further ineffective
toward B. subtilis but found to be active against other
two bacterial strains (Table 3).
Conclusion
In conclusion, we have developed an efficient and
straightforward synthesis of 3-aminoalkylated indoles by
one-pot three-component coupling reaction of a benzal-
dehyde, N-methylaniline, and indole or N-methylindole
using AgOTf as catalyst. Simplicity, easy work up, short
reaction time, environment friendly catalyst, and excel-
lent yield are the advantages which will make this a
practical method for synthesis of 3-aminoalkylated
indoles over existing methods. All the synthesized com-
pounds were evaluated for their antibacterial activities
against both Gram negative and Gram positive bacteria.
Compounds 4b and 4r showed good antibacterial activ-
ity against both Gram positive and Gram negative
strains. However, inversing the property of substituent
(from 4r to 4q) resulted in the significant fall in the
magnitude of antibacterial activity against E. coli.T h i s
study provides insights for further optimizing of substi-
tuted indoles for the discovery of potent antibacterial
agents.
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